Genpact Limited (G)
NYSE: G
· Real-Time Price · USD
42.44
0.40 (0.95%)
At close: May 09, 2025, 3:59 PM
43.78
3.16%
Pre-market: May 12, 2025, 08:00 AM EDT
Genpact Revenue Breakdown
| Period Ending | Dec 30, 2024 | Dec 30, 2023 | Dec 30, 2022 | Dec 30, 2021 | Dec 30, 2020 | Dec 30, 2019 |
|---|---|---|---|---|---|---|
| High Tech and Manufacturing Revenue | 1.79B | 1.68B | 1.65B | 1.51B | 1.39B | 1.35B |
| High Tech and Manufacturing Revenue Growth | +6.23% | +1.72% | +9.46% | +8.69% | +2.98% | n/a |
| Consumer and Healthcare Revenue | 1.69B | 1.57B | 1.63B | 1.48B | 1.26B | 1.11B |
| Consumer and Healthcare Revenue Growth | +7.77% | -3.43% | +9.96% | +16.96% | +14.19% | n/a |
| Financial Services Revenue | 1.29B | 1.23B | 1.18B | 1.02B | 1.08B | 1.08B |
| Financial Services Revenue Growth | +5.18% | +3.46% | +16.48% | -5.78% | +0.03% | n/a |
Operating Expense Breakdown
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 | Dec 31, 2020 | Sep 30, 2020 | Jun 30, 2020 | Mar 31, 2020 | Dec 31, 2019 | Sep 30, 2019 | Jun 30, 2019 | Mar 31, 2019 | Dec 31, 2018 | Sep 30, 2018 | Jun 30, 2018 | Mar 31, 2018 | Dec 31, 2017 | Sep 30, 2017 | Jun 30, 2017 | Mar 31, 2017 | Dec 31, 2016 | Sep 30, 2016 | Jun 30, 2016 | Mar 31, 2016 | Dec 31, 2015 | Sep 30, 2015 | Jun 30, 2015 | Mar 31, 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Selling, General, and Administrative Revenue | 249.16M | 243.31M | 239.97M | 235.54M | 237.42M | 229.73M | 229.43M | 216.49M | 236.56M | 231.44M | 233.1M | 237.3M | 244.86M | 215.96M | 204.17M | 200.73M | 207.86M | 198.34M | 186.31M | 194.38M | 212.65M | 194.54M | 196.31M | 191.4M | 178.58M | 168.01M | 176.17M | 171.11M | 188.99M | 172.09M | 167.9M | 160.86M | 170.71M | 156.97M | 165.2M | 160.15M | 165.41M | 144.72M | 149.23M | 148.75M |
| Selling, General, and Administrative Revenue Growth | +2.40% | +1.39% | +1.88% | -0.79% | +3.35% | +0.13% | +5.98% | -8.49% | +2.21% | -0.71% | -1.77% | -3.09% | +13.38% | +5.77% | +1.71% | -3.43% | +4.80% | +6.45% | -4.15% | -8.59% | +9.31% | -0.90% | +2.57% | +7.18% | +6.29% | -4.63% | +2.96% | -9.46% | +9.82% | +2.50% | +4.38% | -5.77% | +8.76% | -4.98% | +3.15% | -3.18% | +14.30% | -3.02% | +0.32% | n/a |
| Research and Development Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 19.12M | n/a | n/a | n/a | n/a | n/a | 205K | 375K | 347K | 4.53M | n/a | n/a | n/a | 3.51M | n/a | 338K | n/a | n/a | n/a | 452K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| Research and Development Revenue Growth | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | n/a | n/a | -100.00% | -45.33% | +8.07% | -92.34% | n/a | n/a | n/a | -100.00% | n/a | -100.00% | n/a | n/a | n/a | -100.00% | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |